RECRUITING

Meeting an Unmet Need in Multiple Sclerosis

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary objectives of this study is to examine the efficacy of the Unified Protocol in decreasing depression and anxiety among individuals with MS and the secondary outcomes (e.g., improved well-being, QOL, coping, etc.) that may occur in tandem.

Official Title

Meeting an Unmet Need in Multiple Sclerosis (MS): An Evaluation of the Effectiveness of a Transdiagnostic Psychological Treatment and Its Outcomes

Quick Facts

Study Start:2023-04-10

Study Completion:2026-04-30

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05953519

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Diagnosis of multiple sclerosis * 18 years of age or older * Experiencing significant depression and/or anxiety * English-speaking * Able to provide informed consent * Access to the internet	* History of any other neurological illness (e.g. traumatic brain injury, epilepsy, dementia) * Current participation in another randomized controlled trial * Cognitive impairment that would affect my ability to fully participate in the group * Unable to attend group sessions * Active participation in another formal clinical group or psychological therapy * Any other medical or psychological condition that, in the judgement of the investigators, prevents successful participation in the study

Inclusion Criteria

Exclusion Criteria

* Diagnosis of multiple sclerosis
* 18 years of age or older
* Experiencing significant depression and/or anxiety
* English-speaking
* Able to provide informed consent
* Access to the internet

* History of any other neurological illness (e.g. traumatic brain injury, epilepsy, dementia)
* Current participation in another randomized controlled trial
* Cognitive impairment that would affect my ability to fully participate in the group
* Unable to attend group sessions
* Active participation in another formal clinical group or psychological therapy
* Any other medical or psychological condition that, in the judgement of the investigators, prevents successful participation in the study

Contacts and Locations

Study Contact

Belinda L Washington, BA

CONTACT

973-324-8446

bwashington@kesslerfoundation.org

Lauren B Strober, PhD

CONTACT

973-324-8459

lstrober@kesslerfoundation.org

Study Locations (Sites)

Kessler Foundation

East Hanover, New Jersey, 07936

United States

Collaborators and Investigators

Sponsor: Kessler Foundation

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-10

Study Completion Date2026-04-30

Study Record Updates

Study Start Date2023-04-10

Study Completion Date2026-04-30

Terms related to this study

Additional Relevant MeSH Terms

Multiple Sclerosis